Bavarian Nordic Tests Mpox Vaccine in 2- to 11-Year-Olds, Critics Question Safety and Need

Critics told The Defender the trials are flawed because they compare the vaccine’s safety in kids to its safety in adults rather than to a placebo. They also cited serious side effects, including myocarditis, associated with the vaccine.